| 英文别名 |
(3beta,5alpha)-ergost-8(14)-en-3-ol;(3b,5a)-Ergost-8(14)-en-3b-ol;.alpha.-Ergostenol;Ergost-8(14)-en-3-ol, (3.beta.,5.alpha.)-;(24S)-beta-Methyl cholest-8(14)-enol;(24S)-beta-Methyl cholest-8(14)-enol;SCHEMBL4429574;SCHEMBL4429574;5.alpha.-Ergost-8(14)-en-3.beta.-ol;5.alpha.-Ergost-8(14)-en-3.beta.-ol;Ergost-8(14)-en-3-ol;Ergost-8(14)-en-3-ol;Ergost-8(14)-en-3-ol,5.alpha.)-;Ergost-8(14)-en-3-ol,5.alpha.)-;(3beta,5alpha,24S)-Ergost-8(14)-en-3-ol;(3beta,5alpha,24S)-Ergost-8(14)-en-3-ol;DTXSID10310283;DTXSID10310283;DTXSID70871800;DTXSID70871800;5alpha-Ergost-8(14)-en-3beta-ol;5alpha-Ergost-8(14)-en-3beta-ol;NSC224270;NSC224270;alpha-Ergostenol;alpha-Ergostenol;AWYDNKRGSOPYQB-ZHYOCZQLSA-N;AWYDNKRGSOPYQB-ZHYOCZQLSA-N;NSC-224270;NSC-224270;5alpha-Ergosta-8(14)-ene-3beta-ol;5alpha-Ergosta-8(14)-ene-3beta-ol;632-32-6;632-32-6;UNII-Z3RI2342BX;UNII-Z3RI2342BX;C19652;C19652;(3.BETA.,5.ALPHA.)-ERGOST-8(14)-EN-3-OL;(3.BETA.,5.ALPHA.)-ERGOST-8(14)-EN-3-OL;(3S,5S,9R,10S,13R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5S,9R,10S,13R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;delta8(14)-Ergostenol;delta8(14)-Ergostenol;Ergost-8(14)-en-3beta-ol;Ergost-8(14)-en-3beta-ol;Q27294955;Q27294955;.ALPHA.-ERGOSTENOL [MI];.ALPHA.-ERGOSTENOL [MI];LMST01030113;LMST01030113;CHEBI:181925;CHEBI:181925;(3beta,5alpha)-Ergost-8(14)-en-3-ol;(3beta,5alpha)-Ergost-8(14)-en-3-ol;HY-N12501;HY-N12501;CS-0926322;CS-0926322;Ergost-8(14)-en-3-ol #;Ergost-8(14)-en-3-ol #;Z3RI2342BX;Z3RI2342BX;alpha-Ergostenol [MI];alpha-Ergostenol [MI];.DELTA.8(14)-Ergostenol;.DELTA.8(14)-Ergostenol;SCHEMBL4429572;SCHEMBL4429572 |
